Confirmatory Phase II/III Study Assessing Efficacy, Immunogenicity and Safety of IC43

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
This is a confirmatory, randomized, placebo-controlled, multi-center, double-blinded phase II/III study. The study population consists of male or female intensive care unit (ICU) patients with a need for mechanical ventilation for more than 48 hours, aged between 18 and 80 years.
Epistemonikos ID: 7f5fde11eb19c8335434eb14a89e8520b7b83cbd
First added on: May 10, 2024